Open Government Portal
The Canadian product safety information for lorazepam and midazolam warn that they should not be used during pregnancy. The Canadian …
Health Canada reviewed the potential risk of severe bone damage (osteonecrosis) with bisphosphonate use because of product information updates in …
Health Canada has completed a safety review on the potential risk of BIA-ALCL, following an increase in the number of …
Health Canada carried out a safety review of all the available evidence to evaluate the risk of side effects related …
Clozapine is a prescription drug authorized for sale in Canada to manage symptoms of schizophrenia when other drugs have not …
Codeine is converted to morphine in the liver. Some people have genetic variations of liver enzymes which cause codeine to …
In 2013 and 2015, Health Canada carried out safety reviews on codeine-containing products as they relate to the risk of …
A safety review was carried out after Health Canada received a report from the European Medicines Agency, which linked hearing …
Diclectin is a drug authorized in Canada to treat nausea and vomiting in pregnancy (i.e. morning sickness). The safety of …
A safety review was carried out by Health Canada to evaluate the increased risk of heart failure with the use …